| Ad-MVF | Adipose-tissue Derived Microvascular Fragments |
| AECs | Amniotic Epithelial Cells |
| AMCs | Amniotic Mesenchymal Cells |
| ASC | Adipose Stromal Cells |
| ATRA | All-trans Retinoic Acid |
| ATMPs | Advanced Therapy Medicinal Products |
| AV-loop | Arteriovenous Loop |
| BASS | Bioengineered Artificial Skin Substitutes |
| BM-MSC | Bone Marrow Mesenchymal Stem Cells |
| CEA | Cultured Epidermal Autograft |
| DCs | Dendritic Cells |
| DFUs | Diabetic Foot Ulcers |
| dsASCs | Discarded Skin Adipose Stromal Cells |
| GCP | Good Clinical Practice |
| GMP | Good Manufacturing Practice |
| EC | Endothelial Cells |
| ECM | Extracellular Matrix |
| EMA | European Medicines Agency |
| EPCs | Endothelial Progenitor Cells |
| FDA | Food and Drug Administration |
| FDCA | Food, Drug and Cosmetic Act |
| FGF | Fibroblasts Growth Factor |
| HAM | Human Amniotic Membrane |
| HBOEC | Human Blood Outgrowth Endothelial Cells |
| HDMEC | Human Dermal Microvascular Endothelial Cells |
| HUVEC | Human Umbilical Vein Endothelial Cells |
| IL | Interleukin |
| IRB | International Review Board |
| MHC | Major Histocompatibility Complex |
| NK | Natural Killer |
| PEG | Polyethyleneglycol |
| PHSA | Public Health Services Act |
| STSG | Split-Thickness Skin Grafts |
| SVF | Stromal Vascular Fraction |
| TBSA | Total Body Surface Area |
| TGF | Transformant Growth Factor |
| VEGF | Vascular Endothelial Growth Factor |
| VLUs | Venous Leg Ulcers |